Having trouble accessing articles? Reset your cache.

Custirsen sodium: Phase III started

Teva and OncoGenex began the open-label, international Phase III SYNERGY trial to evaluate docetaxel/prednisone with

Read the full 150 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE